Cancer · 2003 · 56 citations · 20 references
MedicineGeriatric MedicineOncologyAgingApoptosisNeoplasiaApoptosis In CancerCentral Nervous System TumorsSkull Base SurgerySkull Base TumorsChordoma RecurrenceClinical Outcome MeasurementClinicopathologic FeaturesMalignant Skull Base TumorsSkull Base InvolvementSkull Base Malignancies
BACKGROUND: To the authors' knowledge, little is known regarding the relation between the proliferative ability and clinicopathologic parameters in skull base chordomas (SBCs) and nonskull base chordomas (NSBCs). METHODS: The authors investigated 122 conventional chordomas for their clinicopathologic parameters, proliferative ability (MIB-1 labeling index [LI]) and clinical outcome. RESULTS: Primary NSBCs were found to affect more elderly patients and demonstrated a higher MIB-1 LI compared with primary SBCs. Mitosis was more commonly noted in recurrent NSBCs compared with primary NSBCs. Apoptosis was more frequent in elderly patients than in younger patients with regard to both SBCs and NSBCs. Apoptosis also was found to be correlated with necrosis in SBCs, suggesting a common factor for the two different types of cell death. Mucoid matrix was reported to be more abundant in NSBCs than in SBCs, and appeared to occur more often in elder NSBC patients compared with younger NSBC patients. This indicates that it is produced in the later stages of tumorigenesis. In SBCs, several clinicopathologic parameters were found to be correlated with MIB-1 LI. Among them, increased age, recurrence, and nuclear pleomorphism were the only independent factors found to indicate a higher MIB-1 LI. No such parameters were found in NSBCs. However, in these lesions, prognosis was significantly poorer in those cases with nuclear pleomorphism compared with those without. CONCLUSIONS: The results of the current study suggest that nuclear pleomorphism is a prognostic indicator in NSBCs. The proliferative ability of SBCs appears to be closely associated with patient age, clinical status (recurrence), and nuclear pleomorphism.
20
Chordomas and cartilaginous tumors at the skull base
M. Joan Heffelfinger, David C. Dahlin, Collin S. MacCarty et al. · Cancer · 1973 · 627 citations · Full text
Prognostic factors in chordoma of the sacrum and mobile spine
Peter Bergh, Lars‐Gunnar Kindblom, B Gunterberg et al. · Cancer · 2000 · 580 citations
Clinical and pathologic review of 48 cases of chordoma
Tyvin A. Rich, Alan L. Schiller, Herman D. Suit et al. · Cancer · 1985 · 391 citations · Full text
Intracranial chordomas: a clinicopathological and prognostic study of 51 cases
Peter Forsyth, Terrence L. Cascino, Edward G. Shaw et al. · Journal of neurosurgery · 1993 · 323 citations